Miami, FL, United States of America

Ana C Edwards


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Ana C Edwards

Introduction

Ana C Edwards is a notable inventor based in Miami, FL, whose contributions have led to significant advancements in the field of immunology. With a strong focus on major histocompatibility complex (MHC) molecules, her work has opened new avenues for understanding and manipulating immune responses.

Latest Patents

Ana C Edwards holds one patent titled "MHC complexes and uses thereof." This innovative patent relates to the creation of novel complexes that consist of MHC molecules, which play a vital role in the immune system's ability to present peptides. The patent specifically highlights MHC fusion complexes that incorporate a peptide-binding groove along with a presenting peptide that is covalently linked to the MHC protein. The applications of this invention are broad, including in vitro screens to identify peptides that can modulate T cell activity, methods to suppress immune responses in mammals, and techniques to induce immune responses.

Career Highlights

Ana currently works at Altor Bioscience Corporation, where she collaborates with fellow scientists on pioneering research that aims to better understand immune modulation. Her work has placed her at the forefront of immunology research, contributing her expertise to the development of new therapeutic approaches.

Collaborations

Throughout her career, Ana has engaged with notable colleagues, including Hing C Wong and Peter Rhode. Their combined efforts in research have facilitated significant advancements in immunological applications, showcasing the importance of teamwork in scientific innovation.

Conclusion

Ana C Edwards represents the spirit of innovation in the field of immunology. Her contributions, particularly through her patent on MHC complexes, demonstrate her commitment to enhancing our understanding of immune responses. As she continues her work at Altor Bioscience Corporation, it is clear that her efforts will have lasting impacts on the pursuit of new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…